(RTTNews) - Medical technology company Zynex, Inc. (ZYXI) announced Tuesday that it has received clearance from the U.S. Food and Drug Administration for the next generation M-Wave Neuromuscular ...
Contralaterally controlled functional electrical stimulation is linked to reduced poststroke arm impairment vs neuromuscular electrical stimulation, a new trial shows.
The case series found consistent improvements in outcomes, demonstrating a unique use in management of MS symptoms AUSTIN, Texas, Aug. 24, 2023 /PRNewswire/ -- A case series conducted by Dr. Courtney ...
Zynex (NASDAQ:ZYXI) has received FDA clearance for its neuromuscular electrical stimulation device M-Wave. M-Wave is a successor product to the company’s E-Wave device, which has been available since ...
ENGLEWOOD, Colo., Nov. 13, 2023 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain ...
What if you could rehab your knee while performing your regular daily routine? Dallas-based Articulate Labs is on a mission to allow patients to do just that with a wearable device that stimulates the ...
CRESTWOOD, Ky.--(BUSINESS WIRE)--Applying non-invasive electrical stimulation to the expiratory abdominal muscles may reduce abdominal muscle atrophy and markedly reduce the number of days adult ...
The US Food and Drug Administration is again proposing a ban on electrical stimulation devices used to reduce or stop self-injurious or aggressive behavior, the agency said in a statement Monday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback